F

Fresenius Medical Care AG & Co KGaA
OTC:FMCQF

Watchlist Manager
Fresenius Medical Care AG & Co KGaA
OTC:FMCQF
Watchlist
Price: 45.17 USD Market Closed
Market Cap: $13.3B

Wall St Price Targets

FMCQF Price Targets Summary
Fresenius Medical Care AG & Co KGaA

Wall Street analysts forecast FMCQF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FMCQF is 48.98 USD with a low forecast of 24.77 USD and a high forecast of 71.97 USD.

Lowest Forecast
Price Target
24.77 USD
45% Downside
Average Forecast
Price Target
48.98 USD
8% Upside
Highest Forecast
Price Target
71.97 USD
59% Upside
Fresenius Medical Care AG & Co KGaA Competitors:
Price Targets
APO
Apollo Global Management Inc
29% Upside
PHVS
Pharvaris NV
40% Upside
OGI
OrganiGram Holdings Inc
114% Upside
BLFS
BioLife Solutions Inc
15% Upside

Revenue
Forecast

5% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
5% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 2%.

Gross Profit
Forecast

2% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
2% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 5%.

Operating Income
Forecast

0% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
0% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 3 years is 11%.

Pre-Tax Income
Forecast

0% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
0% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 12%.

Net Income
Forecast

0% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
0% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 12%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is FMCQF's stock price target?
Price Target
48.98 USD

According to Wall Street analysts, the average 1-year price target for FMCQF is 48.98 USD with a low forecast of 24.77 USD and a high forecast of 71.97 USD.

What is the Revenue forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 2%.

What is the Gross Profit forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 5%.

What is the Operating Income forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 3 years is 11%.

What is the Pre-Tax Income forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 12%.

What is the Net Income forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett